Dr Charles Vega believes that primary care will be the chief clinical setting for application of new blood-based biomarkers.

An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...

Weill Cornell Medicine researchers have received a five-year $6.2 million grant from the National Institute on Aging, part of the National Institutes of Health, to build a portable, high-resolution ...

In a promising development for Alzheimer’s disease diagnostics, Veravas, Inc. and Phanes Biotech have announced their ...

Dr. Najeeb Qadi, Director of the Neuroscience Centre at KFSHRC, said: “The signing of this MoU between KFSHRC & Lilly ...

MRI or PET scans are not always covered by Medicare or even other insurance,” Ighodaro said. “If I, as a neurologist, cannot ...

Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...

We asked Dr. Joanne Pike, CEO of the Alzheimer's Association to help explain the challenges and hopes when it comes to this debilitating disease.

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

Blood-based diagnostic tests are gaining traction as a potential method for the early detection of Alzheimer’s disease, ...

Healthy obesity is defined as having a BMI of 25 kg/m² or higher without metabolic diseases or with only one metabolic ...

Researchers from the International Working Group recommend categorizing biomarker-positive, cognitively normal individuals as ...